Bollard Group LLC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 223 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2019. The put-call ratio across all filers is 0.36 and the average weighting 0.3%.

Quarter-by-quarter ownership
Bollard Group LLC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q4 2020$1,121,000
+20.9%
10,0000.0%0.04%
+27.3%
Q3 2020$927,000
+18.8%
10,0000.0%0.03%
+6.5%
Q2 2020$780,000
+33.3%
10,0000.0%0.03%
+19.2%
Q1 2020$585,000
-27.0%
10,0000.0%0.03%0.0%
Q4 2019$801,000
+9.0%
10,0000.0%0.03%0.0%
Q3 2019$735,000
-80.6%
10,000
-78.9%
0.03%
-81.8%
Q1 2019$3,786,000
+48.5%
47,3000.0%0.14%
+27.7%
Q4 2018$2,550,000
-28.2%
47,300
+4.0%
0.11%
-21.7%
Q3 2018$3,552,000
+5.6%
45,500
-14.2%
0.14%
-7.7%
Q2 2018$3,364,000
-4.1%
53,000
+38.6%
0.16%
-10.9%
Q1 2018$3,508,00038,2500.17%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q2 2019
NameSharesValueWeighting ↓
TRV GP II, LLC 878,875$70,354,00045.87%
CVI Holdings, LLC 200,000$16,010,00015.16%
Foresite Capital Management III, LLC 467,682$37,438,0009.74%
Casdin Capital, LLC 848,648$67,934,0007.46%
BVF INC/IL 564,965$45,225,0005.06%
Ghost Tree Capital, LLC 240,000$19,212,0005.02%
DAFNA Capital Management LLC 119,718$9,583,0004.13%
HHLR ADVISORS, LTD. 1,498,516$119,956,0003.34%
Opaleye Management Inc. 130,000$10,407,0002.88%
Perceptive Advisors 1,271,054$101,748,0002.87%
View complete list of BLUEPRINT MEDICINES CORP shareholders